ID24528A - Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein - Google Patents

Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein

Info

Publication number: ID24528A
Authority: ID; Indonesia
Prior art keywords: hemisulfate; electryptants; cafein; compositions; pct
Prior art date: 1997-07-03

Application number

IDW991585A

Other languages

English (en)

Indonesian (id)

Inventor

Valerie Denise Harding

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-03

Filing date

1998-07-01

Publication date

2000-07-20

1997-07-03 Priority claimed from GBGB9714081.8A external-priority patent/GB9714081D0/en

1998-07-01 Application filed by Pfizer filed Critical Pfizer

2000-07-20 Publication of ID24528A publication Critical patent/ID24528A/id

Links

229940079593 drug Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
IYVZCNNIKYUHHM-WXMGBDCWSA-N OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 Chemical compound OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 IYVZCNNIKYUHHM-WXMGBDCWSA-N 0.000 abstract 1
229960001948 caffeine Drugs 0.000 abstract 1
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDW991585A 1997-07-03 1998-07-01 Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein ID24528A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9714081.8A GB9714081D0 (en)	1997-07-03	1997-07-03	Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en)	1997-07-03	1997-08-28	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ID24528A true ID24528A (id)	2000-07-20

Family

ID=26311826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991585A ID24528A (id)	1997-07-03	1998-07-01	Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein

Country Status (30)

Country	Link
US (1)	US6166025A (de)
EP (1)	EP0999841B1 (de)
JP (1)	JP3350061B2 (de)
CN (1)	CN1145486C (de)
AT (1)	ATE206921T1 (de)
AU (1)	AU724728B2 (de)
BG (1)	BG103930A (de)
BR (1)	BR9810658A (de)
CA (1)	CA2292673C (de)
DE (1)	DE69802097T2 (de)
DK (1)	DK0999841T3 (de)
DZ (1)	DZ2549A1 (de)
EA (1)	EA002174B1 (de)
ES (1)	ES2163291T3 (de)
HR (1)	HRP990416B1 (de)
HU (1)	HUP0004468A3 (de)
ID (1)	ID24528A (de)
IL (1)	IL133206A0 (de)
IS (1)	IS5283A (de)
MA (1)	MA26518A1 (de)
NO (1)	NO312993B1 (de)
NZ (1)	NZ501419A (de)
OA (1)	OA11227A (de)
PL (1)	PL337803A1 (de)
PT (1)	PT999841E (de)
SI (1)	SI0999841T1 (de)
SK (1)	SK284462B6 (de)
TR (1)	TR199903332T2 (de)
UY (1)	UY25078A1 (de)
WO (1)	WO1999001135A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9816556D0 (en) *	1998-07-30	1998-09-30	Pfizer Ltd	Therapy
GB9825988D0 (en)	1998-11-27	1999-01-20	Pfizer Ltd	Indole derivatives
GB9922963D0 (en) *	1999-09-28	1999-12-01	Pfizer Ltd	Polymorphic salt
WO2000064448A1 (en)	1999-04-27	2000-11-02	Board Of Regents, The University Of Texas System	A composition and method for treatment of cerebral ischemia
GB9915231D0 (en)	1999-06-29	1999-09-01	Pfizer Ltd	Pharmaceutical complex
IL136961A0 (en) *	1999-06-30	2001-06-14	Pfizer Prod Inc	5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine
CO5190664A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
CO5190678A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia combinada para el tratamiento de la migrana
GB9923314D0 (en)	1999-10-01	1999-12-08	Pfizer Ltd	Acylation process
US6579898B2 (en) *	2001-03-01	2003-06-17	Pfizer Inc.	Compositions having improved bioavailability
WO2003020977A2 (en) *	2001-08-31	2003-03-13	The University Court Of The University Of Glasgow	Nucleotide repeats assay
US7404489B1 (en)	2003-03-04	2008-07-29	Qol Medical, Llc	Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US7132549B2 (en)	2003-05-30	2006-11-07	Pfizer Inc.	Process
GB0312478D0 (en) *	2003-05-30	2003-07-09	Pfizer Ltd	Improved process
GB2407498B (en) *	2003-10-30	2008-06-11	Cipla Ltd	Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
JP2008516998A (ja) *	2004-10-22	2008-05-22	ジンショウ，コウ	可食用酸と／またはその酸性塩とコーヒーを含む薬剤組成物と無毒性コーヒー
US8506934B2 (en)	2005-04-29	2013-08-13	Robert I. Henkin	Methods for detection of biological substances
WO2007022345A2 (en) *	2005-08-17	2007-02-22	Fleming And Company, Pharmaceuticals	Vitamin b12 nasal spray and method of use
US20070041905A1 (en) *	2005-08-19	2007-02-22	Hoffman Rebecca S	Method of treating depression using a TNF-alpha antibody
WO2008095136A2 (en)	2007-01-31	2008-08-07	Henkin Robert I	Methods for detection of biological substances
FR2926721B1 (fr) *	2008-01-30	2011-07-22	Philippe Perovitch	Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
US8580801B2 (en)	2008-07-23	2013-11-12	Robert I. Henkin	Phosphodiesterase inhibitor treatment
JP2012036167A (ja) *	2010-07-16	2012-02-23	Taisho Pharmaceutical Co Ltd	内服液剤
US8915245B2 (en) *	2010-10-07	2014-12-23	Vapotherm, Inc.	Nebulizer systems, apparatus and methods for respiratory therapy
JP5887894B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
JP5887893B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
ES2744542T3 (es) *	2013-03-15	2020-02-25	Robert I Henkin	Inhibidores de fosfodiesterasa para tratar trastornos gustativos y olfativos
US10426911B2 (en)	2013-08-08	2019-10-01	Vapotherm, Inc.	Respiratory therapy condensation adaptor
NL1040474C2 (en) *	2013-10-31	2015-05-04	Veramed B V	Nasal compositions stimulating ciliary activity.
US10598672B2 (en)	2014-02-18	2020-03-24	Cyrano Therapeutics, Inc.	Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
JP6097787B2 (ja) *	2015-06-09	2017-03-15	パルファーマシューティカル，インコーポレーテッド	鼻内送達用シアノコバラミン低粘度水性製剤
FR3053334B1 (fr) *	2016-06-30	2018-07-27	L'oreal	Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de compose de xanthine
WO2021194893A1 (en)	2020-03-24	2021-09-30	Cyrano Therapeutics, Inc.	Treatment of chemosensory dysfunction from a coronavirus infection
AU2024274892A1 (en) *	2023-05-24	2025-12-11	Defuse Technologies, LLC	Desensitized fertilizer compositions and methods of making same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents

1998
- 1998-07-01 SK SK1828-99A patent/SK284462B6/sk unknown
- 1998-07-01 HR HR970276A patent/HRP990416B1/xx not_active IP Right Cessation
- 1998-07-01 EP EP98940152A patent/EP0999841B1/de not_active Expired - Lifetime
- 1998-07-01 HU HU0004468A patent/HUP0004468A3/hu unknown
- 1998-07-01 DE DE69802097T patent/DE69802097T2/de not_active Expired - Fee Related
- 1998-07-01 BR BR9810658-9A patent/BR9810658A/pt not_active Application Discontinuation
- 1998-07-01 DK DK98940152T patent/DK0999841T3/da active
- 1998-07-01 UY UY25078A patent/UY25078A1/es not_active IP Right Cessation
- 1998-07-01 ID IDW991585A patent/ID24528A/id unknown
- 1998-07-01 DZ DZ980159A patent/DZ2549A1/xx active
- 1998-07-01 NZ NZ501419A patent/NZ501419A/xx unknown
- 1998-07-01 SI SI9830068T patent/SI0999841T1/xx unknown
- 1998-07-01 PL PL98337803A patent/PL337803A1/xx unknown
- 1998-07-01 JP JP50638199A patent/JP3350061B2/ja not_active Expired - Fee Related
- 1998-07-01 TR TR1999/03332T patent/TR199903332T2/xx unknown
- 1998-07-01 MA MA25150A patent/MA26518A1/fr unknown
- 1998-07-01 AU AU88569/98A patent/AU724728B2/en not_active Ceased
- 1998-07-01 CN CNB988066289A patent/CN1145486C/zh not_active Expired - Fee Related
- 1998-07-01 IL IL13320698A patent/IL133206A0/xx unknown
- 1998-07-01 CA CA002292673A patent/CA2292673C/en not_active Expired - Fee Related
- 1998-07-01 ES ES98940152T patent/ES2163291T3/es not_active Expired - Lifetime
- 1998-07-01 WO PCT/EP1998/004176 patent/WO1999001135A1/en not_active Ceased
- 1998-07-01 AT AT98940152T patent/ATE206921T1/de not_active IP Right Cessation
- 1998-07-01 US US09/402,239 patent/US6166025A/en not_active Expired - Fee Related
- 1998-07-01 EA EA199901100A patent/EA002174B1/ru not_active IP Right Cessation
- 1998-07-01 PT PT98940152T patent/PT999841E/pt unknown
1999
- 1999-11-30 IS IS5283A patent/IS5283A/is unknown
- 1999-11-30 BG BG103930A patent/BG103930A/xx unknown
- 1999-12-01 NO NO19995887A patent/NO312993B1/no unknown
- 1999-12-03 OA OA9900271A patent/OA11227A/en unknown

Also Published As

Publication number	Publication date
JP2000516262A (ja)	2000-12-05
ATE206921T1 (de)	2001-11-15
AU724728B2 (en)	2000-09-28
HK1029282A1 (en)	2001-03-30
CN1261279A (zh)	2000-07-26
EA199901100A1 (ru)	2000-08-28
HRP990416A2 (en)	2000-04-30
JP3350061B2 (ja)	2002-11-25
PL337803A1 (en)	2000-09-11
CA2292673C (en)	2003-04-22
DZ2549A1 (fr)	2003-02-08
IL133206A0 (en)	2001-03-19
DE69802097T2 (de)	2002-03-14
CA2292673A1 (en)	1999-01-14
PT999841E (pt)	2002-02-28
DK0999841T3 (da)	2001-11-19
SK284462B6 (sk)	2005-04-01
MA26518A1 (fr)	2004-12-20
NO995887D0 (no)	1999-12-01
NO312993B1 (no)	2002-07-29
BG103930A (en)	2000-07-31
NZ501419A (en)	2000-09-29
EP0999841B1 (de)	2001-10-17
AU8856998A (en)	1999-01-25
HUP0004468A3 (en)	2004-07-28
EP0999841A1 (de)	2000-05-17
UY25078A1 (es)	2000-12-29
BR9810658A (pt)	2000-10-03
ES2163291T3 (es)	2002-01-16
EA002174B1 (ru)	2002-02-28
SK182899A3 (en)	2000-09-12
IS5283A (is)	1999-11-30
SI0999841T1 (de)	2001-12-31
NO995887L (no)	2000-03-02
HUP0004468A2 (hu)	2001-10-28
OA11227A (en)	2003-07-18
WO1999001135A1 (en)	1999-01-14
TR199903332T2 (xx)	2000-09-21
HRP990416B1 (en)	2002-04-30
US6166025A (en)	2000-12-26
DE69802097D1 (de)	2001-11-22
CN1145486C (zh)	2004-04-14

Publication	Publication Date	Title
DE69802097D1 (de)	2001-11-22	Eletriptanhemisulfat und kaffein enthaltende pharmazeutische zusammenstellungen
IL133825A0 (en)	2001-04-30	Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
DE69727922D1 (de)	2004-04-08	Schnell zerfallende orale dosierungsform
IL149163A0 (en)	2002-11-10	Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
YU68199A (sh)	2002-06-19	Farmaceutske formulacije koje sadrže vorikonazol
MX9707431A (es)	1997-12-31	Inhibidores de la proteina cinasa c.
DE69734734D1 (de)	2005-12-29	Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
EP1037673A4 (de)	2002-05-02	Geladene lipide und deren verwendung
SI0989851T1 (en)	2003-04-30	Self-emulsifying formulation for acidic lipophilic compounds
IL108234A0 (en)	1994-04-12	Pharmaceutical composition containing galanthamine
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
IT1314185B1 (it)	2002-12-06	Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
FR2763592B1 (fr)	1999-07-16	Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
FR2700166B1 (fr)	1995-02-17	Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex
ZA935045B (en)	1994-02-07	Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
EP1263435A4 (de)	2004-08-11	Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose
MY119643A (en)	2005-06-30	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
IT1314204B1 (it)	2002-12-06	Complessi di rutenio con elevata attivita' antitumorale
ECSP982578A (es)	1999-02-11	Composiciones farmaceuticas que contienen eletriptan hemisulfato
MY152490A (en)	2014-10-15	New oral formulation